Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway.
Fujii T, Yonemitsu Y, Onimaru M, Tanii M, Nakano T, Egashira K, Takehara T, Inoue M, Hasegawa M, Kuwano H, Sueishi K. Fujii T, et al. Among authors: tanii m. Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2483-9. doi: 10.1161/01.ATV.0000244684.23499.bf. Epub 2006 Sep 7. Arterioscler Thromb Vasc Biol. 2006. PMID: 16960104
VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.
Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R, Hasegawa M, Nishikawa S, Sueishi K. Onimaru M, et al. Among authors: tanii m. Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1685-96. doi: 10.1152/ajpheart.00015.2009. Epub 2009 Sep 4. Am J Physiol Heart Circ Physiol. 2009. PMID: 19734356 Free article.
Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.
Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K. Masaki I, et al. Among authors: tanii m. Circ Res. 2002 May 17;90(9):966-73. doi: 10.1161/01.res.0000019540.41697.60. Circ Res. 2002. PMID: 12016262
Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit.
Shoji T, Yonemitsu Y, Komori K, Tanii M, Itoh H, Sata S, Shimokawa H, Hasegawa M, Sueishi K, Maehara Y. Shoji T, et al. Among authors: tanii m. Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H173-82. doi: 10.1152/ajpheart.00996.2002. Epub 2003 Mar 6. Am J Physiol Heart Circ Physiol. 2003. PMID: 12623787 Free article.
Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, Yanagida E, Shibamoto Y, Ogasawara M, Tsujitani S, Koido S, Nagai K, Shimodaira S, Okamoto M, Yonemitsu Y, Suzuki N, Nagaya M; DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. Among authors: tanii m. J Gastrointest Surg. 2013 Sep;17(9):1609-17. doi: 10.1007/s11605-013-2286-2. Epub 2013 Jul 20. J Gastrointest Surg. 2013. PMID: 23877328
Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis.
Kobayashi M, Shimodaira S, Nagai K, Ogasawara M, Takahashi H, Abe H, Tanii M, Okamoto M, Tsujitani S, Yusa S, Ishidao T, Kishimoto J, Shibamoto Y, Nagaya M, Yonemitsu Y; DC Vaccine Study Group at the Japan Society of Innovative Cell Therapy (J-SICT). Kobayashi M, et al. Among authors: tanii m. Cancer Immunol Immunother. 2014 Aug;63(8):797-806. doi: 10.1007/s00262-014-1554-7. Epub 2014 Apr 29. Cancer Immunol Immunother. 2014. PMID: 24777613 Free PMC article.
16 results